PEPTIDE SYNTHESIS MARKET ANALYSIS

Peptide Synthesis Market, By Product (Reagents & Consumables, Equipment (Peptide Synthesizers, Lyophilizer, Chromatography Equipment)), By Technology (Solid Phase, Liquid Phase, Hybrid and Recombinant), By Application (Therapeutics(Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Infectious Diseases, Others), Diagnosis, Research), By End User (Biopharmaceutical Companies, Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO), Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Global Peptide Synthesis Market- Recent Developments

Research and Development Activities

In June 2022, Evonik, a specialty chemicals company, announced the launch of its new peptide to boost the productivity of cell-culture-based biopharmaceuticals and to improve productivity of monoclonal antibodies, vaccines, viral vectors, and therapeutic cells
In January 2022, Novo Nordisk India division, a leading global healthcare company, launched a peptide in a pill, oral semaglutide, for diabetes management. A GLP-1 receptor analogue (GLP-1 RA), one of the drug classes to treat diabetes, was until now available only in the form of injections...

Business Development Activities by the Market Players

On September 25, 2023, Biosynth, a supplier of critical materials to the life science industry, announced the acquisition of Pepceuticals, a U.K. producer of synthetic peptides with multi-kilogram GMP facilities and fill-finish capabilities designed to support customers from clinical trials to commercial supply.
In April 2021, ISSAR Pharma, the pioneer in peptide technology and peptide drug innovation, announced licensing their peptide-based New Chemical Entities (NCEs), with pre-investigational new drug (IND) filing and a U.S. patent...